-
The Bakersfield Californian - Sat Oct 24, 3:13 pm ET
If you're having a hard time keeping up with the swirl of information surrounding H1N1 (swine) flu, seasonal flu, bird flu and maybe even your chimney flue, you're not alone. So we collected a batch of frequently asked questions and sought out answers.
-
PR Newswire via Yahoo! Finance - Tue Oct 27, 8:00 am ET
Sinovac Biotech Ltd. , a leading provider of biopharmaceutical products in China, announced today that it has received its third purchase order for its H1N1 vaccine, PANFLU.1, from China's Ministry of Industry and Information Technology for the national stockpiling plan.
-
Reuters via Yahoo! News - Sun Oct 25, 3:24 pm ET
U.S. regulators have approved emergency use of one experimental new antiviral drug against pandemic flu and researchers say several more in the pipeline may provide better ways to fight the virus.
-
Foreign Relations - Mon Oct 26, 9:52 am ET
Worldwide, drug companies are scrambling to manufacture a vaccine for H1N1, also known as swine flu, which was declared a pandemic in June 2009. David Fedson , an expert in influenza vaccines and a former consultant to the World Health Organization, says the current distribution system is outmoded, and could slow or restrict the delivery of vaccines to some developing countries.
-
GlobeNewswire via Yahoo! Finance - Mon Oct 26, 8:45 am ET
PHILADELPHIA -- Hemispherx Biopharma, Inc. , announced that the research group headed by Dr. H. Hasegawa, Chief, Laboratory of Mucosal Vaccine Development Virus Research Center, Japanese National Institute of Infectious Diseases , expanded the data on Ampligen, an experimental immunotherapeutic, in the Oct. 23, 2009, issue of Vaccine to include the conveyance of cross-protective immunity against ...
-
EurekAlert! - Tue Oct 20, 11:22 am ET
( Rice University ) Biochemists at Rice University have won $1.5 million in stimulus funding from the National Institutes of Health to scrutinize the influenza A virus for structural clues that could boost the effectiveness of antiviral drugs. The influenza A category includes this year's pandemic H1N1 flu strain, some seasonal varieties of flu and the much-feared H5N1 bird flu.
-
Business Wire via Yahoo! Finance - Mon Oct 26, 7:00 am ET
WEST HAVEN, Conn.----NanoViricides, Inc. , reports that the Company is well financed and its game changing anti-viral drug development programs are progressing successfully. As such, Management knows of no reason for the recent decline in stock price and associated volatility.
-
US News & World Report - Fri Oct 23, 1:07 pm ET
Jon Andrus of the Pan American Health Organization talks about the H1N1 virus.
-
The Star-Ledger - Fri Oct 16, 8:27 pm ET
Staff photo by Britney LillyaTwo mute swans are seen in this file photo on the waters of Mannington Meadows in Mannington Township. The state said sharpshooters killed off 55 of the big birds to thin the flock and test them...
-
KCRA 3 Sacramento - Fri Oct 23, 1:50 pm ET
University of California, Davis, on Friday launched an international effort to find and control diseases that move between wildlife and people in hopes of preventing the next global pandemic and millions of possible deaths.
-
KUTV Salt Lake City - Fri Oct 23, 1:38 pm ET
The H1N1 Vaccine could arrive in Utah in the early part of October. In Salt Lake County, it will likely be administered in Schools.
-
UC Davis News & Information - Fri Oct 23, 11:53 am ET
In hopes of preventing the next global pandemic and a possible death toll into the millions, UC Davis today launches an unprecedented international effort to find and control diseases that move between wildlife and people. The global early warning system, named PREDICT, will be developed with funding of up to $75 million over five years and is one of five new initiatives of the U.S. Agency for ...
-
Market Watch - Thu Oct 22, 4:40 am ET
Swiss pharmaceutical giant Novartis' third-quarter profit is virtually unchanged, as growing sales of cancer and hypertension medications offset charges and declining vaccine sales.
-
Christian News Wire - Thu Oct 22, 9:56 am ET
WASHINGTON, Oct. 22 / Standard Newswire / -- The United States Agency for International Development (USAID) is launching an Emerging Pandemic Threats (EPT) program that builds on the successes of the Agency's long-standing programs in disease surveillance, training, and outbreak response, particularly those addressing avian and pandemic influenza.
-
The Morning Call - Thu Oct 22, 7:06 am ET
Drugmakers show more interest; supplies likely to grow as threat of pandemics increases Vaccine shortages, commonplace a few years ago, soon may be a thing of the past.
